Navigation Links
WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System
Date:1/8/2009

eving market acceptance of new and relatively unproven technologies; (ii) the company will need to raise additional capital to meet its business requirements in the future and the company may not be able to do so on reasonable terms or at all; (iii) the company's proprietary intellectual property rights may not adequately protect its products and technologies; and (iv) the company expects intense competition in its target markets, including from companies that have much greater resources than the company, and there can be no assurance that the company will be able to compete effectively. More detailed information about the company and the risk factors that may affect the realization of forward-looking statements is set forth in the company's filings with the Securities and Exchange Commission, including the company's Annual Report on Form 10-K for the year ended December 31, 2007, and its subsequent Quarterly Reports on Form 10-Q filed with the SEC. Investors and security holders are urged to read this document free of charge on the SEC's web site at www.sec.gov. The company does not undertake to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Vida Communication (on behalf of WaferGen)

Stephanie Diaz (investors)

415-675-7400

sdiaz@vidacommunication.com

Tim Brons (media)

415-675-7400

tbrons@vidacommunication.com


'/>"/>
SOURCE WaferGen Biosystems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. University of Kansas Medical Center to Deploy Velos eResearch System-Wide
2. InteRNA Technologies and VU University Medical Center to Develop microRNA-Based Diagnostics and Therapeutics for Cancer
3. Gene Found Activated in 70% of Prostate Cancer Cases, George Washington University Medical Center Scientists Report
4. American College of Cardiology and Center of Excellence for Simulation Research of Western Michigan University (CESR) Partner for in situ Simulation to Improve Team Communication and Door-to-Balloon (D2B) Time
5. Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics miRview(TM) Squamous Assay
6. Queens University Chooses Xceeds Ziplex(R) System for Translational Research
7. deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
8. The University of Nottingham in the British Midlands Announces Breakthrough in Parkinsons Disease Research
9. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
10. First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan
11. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... -- The Arentz Law Group is currently investigating cases of birth ... who have taken Zyban while pregnant, and given birth to ... contact the law firm immediately for a free legal ... American Journal of Obstetrics & Gynecology  showed that mothers ... giving birth to a child with " left outflow tract ...
(Date:7/7/2015)... 2015 Biobanks - How to ... ,Are you interested in the future ... technological and commercial predictions from 2015. You stay ahead ... research and development, results, opportunities and revenue forecasts. ... you what,s possible for biobanking and associated technology to ...
(Date:7/7/2015)... 2015   Decision Resources Group finds ... patient management in the U.S. versus the EU5. ... and EU5 nephrologists from approximately 1,870 dialysis patient ... most commonly used renal medications in dialysis patients; ... between the two regions.      Other key ...
Breaking Medicine Technology:Smoking cessation drug linked to birth defects when taken during pregnancy 2Biobanking for Medicine: Technology, Industry and Market 2015-2025 2Biobanking for Medicine: Technology, Industry and Market 2015-2025 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 4Biobanking for Medicine: Technology, Industry and Market 2015-2025 5Biobanking for Medicine: Technology, Industry and Market 2015-2025 6Biobanking for Medicine: Technology, Industry and Market 2015-2025 7Biobanking for Medicine: Technology, Industry and Market 2015-2025 8Biobanking for Medicine: Technology, Industry and Market 2015-2025 9Biobanking for Medicine: Technology, Industry and Market 2015-2025 10Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3
... Approves Label Revisions Recommending New Weight-Based Dosing ... Schering-Plough Corporation,(NYSE: SGP ) today reported ... (FDA),has approved label revisions for PEGINTRON(TM) (peginterferon ... chronic hepatitis C,recommending weight-based dosing of REBETOL ...
... Insulin Should Take Note, Researchers Say, Also: ACC ... ALEXANDRIA, Va., March 27 People who have,diabetes ... who do not,have diabetes, a finding that may have ... a study appearing in the April issue of,Diabetes Care., ...
Cached Medicine Technology:Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C 2Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C 3Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C 4Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C 5Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C 6Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C 7Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C 8Reduced Lung Capacity Accelerates With Diabetes 2Reduced Lung Capacity Accelerates With Diabetes 3
(Date:7/7/2015)... ... 2015 , ... Parents and guardians of teenagers or young adults will be ... treatment center for drug and alcohol abuse located in Southwest Michigan. A recently released ... a significant increase in the “club drug” use among high school seniors. The blog ...
(Date:7/7/2015)... ... July 07, 2015 , ... Georgia Partnership for ... communities throughout Georgia, announces the launch of the first ambulance telemedicine program in ... County, GA. The new program will not only provide more immediate patient care, ...
(Date:7/7/2015)... , ... July 07, 2015 ... ... public relations, marketing, and creative design firm, today announced that TimberNook ( ... relations and social media campaign, content strategy, and marketing launch package for ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... as the company’s new Chief Financial Officer, effective July 6th, 2015. Ellen joins ... companies ranging from a multi-billion dollar, global chemical company to early and growth-stage ...
(Date:7/7/2015)... ... July 07, 2015 , ... RadSite™, ... as designated by the Centers for Medicare and Medicaid Services (CMS), announces that ... compatibility with mobile devices. , The most effective websites are those that provide ...
Breaking Medicine News(10 mins):Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2Health News:Georgia Partnership for TeleHealth prepares to Launch First Ambulance Telemedicine Solution in Georgia 2Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2Health News:Office Practicum Announces new CFO 2Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 2Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 3
... Therapeutics Inc., a,privately-held biopharmaceutical company developing first-in-class small,molecule ... diseases, today announced the appointment of Donald J. ... very pleased to welcome Don to our board ... be of great benefit to the Company,as we ...
... France, December 6 Essilor,has strengthened its prescription ... stakes in Sinclair Optical Services and United,Optical, two ... also acquired Premier Optics, Inc., Gold Optical Enterprises, ... Based in Gloucester, England, Sinclair Optical serves the ...
... CHICAGO, Dec. 5 /PRNewswire-FirstCall/ -. Brookdale Senior ... high-quality senior living,communities, announced the launch of ... will be able to access extensive information ... locations that provide independent,living, assisted living, Alzheimer,s ...
... The American Society of,Hematology (ASH), the world,s largest ... who have made notable,contributions to the genetic understanding ... M. Stratton Medal, intended to honor an individual,with ... Vainchenker, MD,PhD, will receive the William Dameshek Prize, ...
... Calif., Dec. 5 With the popularity of,fillers ... for longer,lasting alternatives to prevent facial wrinkles. Dr. ... practice in Beverly Hills,says, "Fillers such as Artefill, ... material. When injected into tissue, all of,these products ...
... Necessary to Accelerate Adoption, WASHINGTON, Dec. ... effort,to improve health care through electronic prescribing ... the bipartisan,legislation introduced by Senate Finance Committee ... Stabenow (D-Mich.), Senator Mel,Martinez (R-Fla.), and endorsed ...
Cached Medicine News:Health News:Arete Therapeutics Appoints Donald Santel to Board of Directors 2Health News:Essilor Acquires Prescription Laboratories in the United Kingdom and the United States 2Health News:Brookdale Senior Living Announces Enhanced Web Site 2Health News:Top Scientists to Receive Prestigious Awards From the American Society of Hematology 2Health News:Top Scientists to Receive Prestigious Awards From the American Society of Hematology 3Health News:Facial Deformity Danger? 2Health News:PCMA Supports Bipartisan Legislation Calling for E-Prescribing Requirement in Medicare 2
19 gauge x 8 mm with 15 cm high pressure extension tube preattached to a 10C ring control syringe. 3 per box....
Angled, 20 gauge x 25 mm cannula with 30 gauge x 5 mm tip. 30 gauge cannula extends into hub 2 mm from end of hub, angled 45 degrees 2.5 mm from tip. 10 per box....
The moist air humidifying chamber is designed for the infusion of humidified air during phakic fluid air exchange. Sterile single-use. 10 per box. Most popular size or model....
Includes one aluminum Fox eye shield and one eye Garter shield cover. Packaged 50 per box. White only....
Medicine Products: